11.11.2012 Views

THE NATURE OF OUR BUSINESS – STABLE GROWTH - Symrise

THE NATURE OF OUR BUSINESS – STABLE GROWTH - Symrise

THE NATURE OF OUR BUSINESS – STABLE GROWTH - Symrise

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

Acquisitions of businesses amounting to € 122.4 million result<br />

from the acquisition of the flavor business from Chr. Hansen and<br />

of the fragrance businesses from Intercontinental Fragrances and<br />

Manheimer Fragrances.<br />

The amortization of recipes is allocated to production and is therefore<br />

included in the cost of sales. The amortization of other intangible<br />

assets is allocated to the respective functional areas included<br />

in the income statement.<br />

8.11. Impairment Testing of Goodwill, Recipes and Trademarks<br />

with Indefinite Useful Lives<br />

Goodwill arising through business combinations has been allocated<br />

to the following two cash-generating units, which are tested<br />

for impairment:<br />

› Flavor & Nutrition<br />

› Scent & Care<br />

The recoverable amount of a business division is determined based<br />

on the value in use as at September 30, 2008. Cash flow projections<br />

are based on the Group’s three year financial planning. A net<br />

tax discounting factor of 8.0% (prior year: 7.6%) was used to discount<br />

cash flow projections.<br />

The carrying amount of goodwill as at September 30, 2008<br />

amounted to € 309.3 million in the Flavor & Nutrition division and<br />

€ 156.1 million in the Scent & Care division. As compared to the<br />

balance sheet reporting date as at December 31, 2008, the estimated<br />

goodwill recognized for the Manheimer acquisition was then<br />

some € 10.6 million ($ 15.0 million) higher. Within the context of<br />

a purchase price reduction made in December 2008, a correspondingly<br />

lower goodwill was derived at the balance sheet reporting<br />

date.<br />

As in the previous year, the total amount (€ 62.1 million) relating to<br />

recipes with indefinite useful lives has been allocated to the Scent<br />

& Care division. In this case, an impairment test was also carried<br />

out as of September 30, 2008, at the level of the cash-generating<br />

unit with the result that no impairment requirement was identified.<br />

Trademarks with indefinite useful lives were also tested for impairment<br />

as at September 30, 2008. No impairment was identified.<br />

An impairment loss of € 35.7 million was recognized in 2003 with<br />

respect to goodwill attributed to the Scent & Care division. The impairment<br />

related to the former Aroma Chemicals business sector.<br />

Key assumptions used in determining the<br />

recoverable amount<br />

The Group determined the value in use as the recoverable amount.<br />

The key assumptions are described below which provided the basis<br />

for management’s cash flow projections used in making the impairment<br />

tests for goodwill, recipes and trademarks.<br />

The value in use was calculated using the discounted cash flow<br />

(DCF) method under which free cash flows are discounted using<br />

the weighted average cost of capital (WACC).<br />

The Group has calculated the cash flows of the individual divisions<br />

during the period from 2008 to 2011 based on varying growth<br />

rates. For 2009, the data used was based on the detailed budget<br />

data for 2009, whereas for the years 2010 and 2011 a constant<br />

growth rate of 4.5% was used for the Flavor & Nutrition division<br />

and a constant growth rate of 3.5% was used for the Scent & Care<br />

division. An overall growth rate of 0.5% was assumed for the year<br />

2012.<br />

The WACC comprises a risk-free interest rate of 4.8%, which is derived<br />

from the interest rate on German federal government bonds,<br />

and a market risk premium of 5.0%. The unlevered beta factor is<br />

0.75 and the levered beta factor is 0.9. The estimated cost of equity<br />

is 9.3% and the cost of debt is 6.3%.<br />

The ICF and Manheimer acquisitions (see note 8.13) were included<br />

in the impairment test as at September 30, 2008.<br />

Applying the assumptions described above, the impairment test<br />

carried out as at September 30, 2008, confirmed that there was<br />

no impairment of either goodwill or recipes. The recoverable<br />

amount was higher than the respective carrying amounts in both<br />

business divisions.<br />

126 Annual Report 2008 <strong>Symrise</strong> AG

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!